{"disease":{"id":"rituximab","name":"rituximab"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01311232","title":"Factors Influencing Hepatitis B Virus Reactivation in Lymphoma Patients Treated With Rituximab","phase":"","overall_status":"COMPLETED","enrollment_count":600,"lead_sponsor_name":"Samsung Medical Center","has_results":false},{"nct_id":"NCT03958916","title":"Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With BL/DLBCL","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT04877496","title":"Responses to COVID19 Vaccination in Patients With a Treatment History of Rituximab.","phase":"","overall_status":"UNKNOWN","enrollment_count":425,"lead_sponsor_name":"Insel Gruppe AG, University Hospital Bern","has_results":false},{"nct_id":"NCT07457944","title":"Efficacy and Safety of Different Doses of Rituximab Therapy in Pemphigus Patients","phase":"","overall_status":"COMPLETED","enrollment_count":275,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT05734794","title":"Study of Rituximab Monotherapy on Children With New-onset Nephrotic Syndrome: A Randomized Controlled Trial","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"The Children's Hospital of Zhejiang University School of Medicine","has_results":false},{"nct_id":"NCT06949241","title":"A Single Cycle of Intravenous Immunoglobulin as Adjuvant to Rituximab in Patients With Pemphigus: A Retrospective Cohort Study at a Tertiary Referral Center","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":76,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT03373019","title":"Chidamide Combined With R-GDP in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":63,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT06530004","title":"Clinical Follow-up Study of Rituximab in the Treatment of Nephrotic Syndrome in Children","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"The First Affiliated Hospital of Xiamen University","has_results":false},{"nct_id":"NCT05332587","title":"Efficacy and Safety of Low-dose Rituximab in the Treatment of Refractory Myasthenia Gravis","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"First Affiliated Hospital, Sun Yat-Sen University","has_results":false},{"nct_id":"NCT05992597","title":"ZR2 Sequential Immunochemotherapy for Newly Treated MCL","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":48,"lead_sponsor_name":"Zhejiang Cancer Hospital","has_results":false},{"nct_id":"NCT03372837","title":"Phase III Study of SyB L-0501 in Combination With Rituximab to Treat Recurrent/Relapsed Diffuse Large B-Cell Lymphoma","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"SymBio Pharmaceuticals","has_results":false},{"nct_id":"NCT07257055","title":"Phase 2 Study of BTKi-Rituximab Induction Followed by Glofitamab Consolidation in High Risk Untreated MCL Patients - WINDOW-4 Study","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT04425824","title":"Toripalimab Combine With Rituximab for Treatment of Relapsed Refractory CD20 Positive Diffuse Large B-cell Lymphoma","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT05324917","title":"Population Pharmacokinetic-pharmacodynamic Study of Rituximab in Children With Blood Diseases","phase":"","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"The Affiliated Hospital of Qingdao University","has_results":false}],"total":14},"guidelines":[],"source":"Drug Landscape verified database"}